Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ: HOLX )

71.41 +0.71 (+1.00%)
Streaming Delayed Price Updated: 12:59 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 385,689
Open 70.45
Bid (Size) 71.38 (2)
Ask (Size) 71.44 (4)
Prev. Close 70.70
Today's Range 70.25 - 71.53
52wk Range 68.61 - 84.49
Shares Outstanding 253,487,389
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments. 
Via Benzinga
Topics Artificial Intelligence Government Stocks
Exposures Artificial Intelligence Political US Equities
How Is The Market Feeling About Hologic?
Via Benzinga

Performance

YTD
-0.46%
-0.46%
1 Month
-1.75%
-1.75%
3 Month
-11.74%
-11.74%
6 Month
-8.31%
-8.31%
1 Year
-3.62%
-3.62%

More News

Read More
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
From Hologic, Inc.
Via Business Wire
FDA Warns Hologic Over BioZorb Manufacturing Violations
Via Benzinga
Exposures Product Safety
Peering Into Hologic's Recent Short Interest
Via Benzinga
Expert Ratings For Hologic
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Looking Into Hologic's Recent Short Interest
Via Benzinga
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
From Hologic, Inc.
Via Business Wire
Hologic Completes Acquisition of Gynesonics, Inc.
From Hologic, Inc.
Via Business Wire
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
From Hologic, Inc.
Via Business Wire
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
From Hologic, Inc.
Via Business Wire
This James Hardie Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Martin Madaus Elected to Hologic Board of Directors
From Hologic, Inc.
Via Business Wire
New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence
From Hologic, Inc.
Via Business Wire
Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations
From Hologic, Inc.
Via Business Wire
Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
Via Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Via Benzinga
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
From Hologic, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.